INCOME TAXES (Details Narrative) (USD $)	Jun. 30, 2012
Income Tax Disclosure [Abstract]
Deferred Tax Asset, attributable to net operating loss carry forwards	$ 5,329,144
Net operating loss carry forwards	15,673,954
Net Operating Loss Carry forwards acquired in reverse acquisition of BMSG	38,616
Net Operating Loss Carry forwards attributable to Bio-Matrix Scientific Group, Inc., BMSG, Regen and Entest	15,635,338
Deferred tax assets, reduced from recorded valuation allowance	$ 0